tetradecanoylphorbol acetate has been researched along with ro 31-9790 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ager, A; Middelhoven, PJ; Roos, D; Verhoeven, AJ | 1 |
| Bendall, LJ; Gu, B; Wiley, JS | 1 |
| Ager, A; Borland, G; Murphy, G | 1 |
| Amit, T; Barkey, RJ; Hochberg, Z; Yogev-Falach, M; Youdim, MB | 1 |
| Bernot, D; Bonardo, B; Deprez-Beauclair, P; Juhan-Vague, I; Lopez, S; Nalbone, G; Peiretti, F | 1 |
5 other study(ies) available for tetradecanoylphorbol acetate and ro 31-9790
| Article | Year |
|---|---|
Involvement of a metalloprotease in the shedding of human neutrophil Fc gammaRIIIB.
Topics: Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Hydroxamic Acids; L-Selectin; Metalloendopeptidases; Neutrophils; Protease Inhibitors; Receptors, IgG; Superoxides; Tetradecanoylphorbol Acetate | 1997 |
Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases.
Topics: Adenosine Triphosphate; B-Lymphocytes; Biomarkers, Tumor; Calcium; Humans; Hydroxamic Acids; L-Selectin; Leukemia, Lymphocytic, Chronic, B-Cell; Metalloendopeptidases; Neoplasm Proteins; Neoplastic Stem Cells; Protease Inhibitors; Receptors, IgE; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Solubility; Tetradecanoylphorbol Acetate | 1998 |
Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Humans; Hydroxamic Acids; Jurkat Cells; L-Selectin; Leukocytes; Metalloendopeptidases; Mice; Monocytes; Protease Inhibitors; Rats; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Tumor Necrosis Factor-alpha | 1999 |
Shedding of growth hormone-binding protein is inhibited by hydroxamic acid-based protease inhibitors: proposed mechanism of activation of growth hormone-binding protein secretase.
Topics: Animals; Carrier Proteins; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Ethylmaleimide; Humans; Hydroxamic Acids; Metalloendopeptidases; Protein Kinase C; Receptors, Somatotropin; Staurosporine; Tetradecanoylphorbol Acetate; Transfection | 2001 |
Modulation of PAI-1 and proMMP-9 syntheses by soluble TNFalpha and its receptors during differentiation of the human monocytic HL-60 cell line.
Topics: Antibodies; Antigens, CD; Cell Differentiation; Cellular Senescence; Collagenases; Enzyme Precursors; HL-60 Cells; Humans; Hydroxamic Acids; Macrophages; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Monocytes; Plasminogen Activator Inhibitor 1; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Solubility; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2003 |